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Abstract
Presently, bone replacement grafts are one of the modalities of therapy for which there is histologic evidence of 
regeneration coronal to the base of the previous osseous defect. Bioactive glasses are used extensively in medicine 
and dentistry. 
This study evaluated the additional efficacy of a bioactive alloplast, PerioGlas, in comparison with open flap de-
bridement only. 8 systemically healthy volunteers were chosen, each having 2 collateral sites with ≥6 mm clinical 
probing depth and radiographic evidence of an intrabony defect. Randomly, one defect was treated with open flap 
debridement plus bioactive glass (test) and the other with open flap debridement alone (control). At baseline, 3, 6, 9 
months measurements were recorded which included plaque index, gingival index, pocket probing depth, clinical 
attachment level, and increase in gingival recession. Standardized radiographs were used to measure defect fill 
and alveolar crest resorption. The data were subjected to statistical analysis. Both treatments showed no significant 
differences between the two groups at any point of time. However, radiographically, bioactive glass group showed 
significant improvement in bone fill over the sites treated with open flap debridement alone. The alloplastic bone 
graft material, PerioGlas, demonstrated clinical advantages beyond that achieved by debridement alone. 
Key words: Bone replacement grafts, alloplast, bioactive glasses, PerioGlas, intrabony defect, soft tissue para-
meters, radiographically.
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Introduction
The pathological hallmark of periodontitis is the destruc-
tion of the supporting structures of the teeth involved. 
The advent of regenerative approaches in contemporary 
periodontics has increased patient’s treatment options 
and enhanced the long- term prognosis of many teeth 
that have advanced periodontal destruction.
At the present time, bone replacement grafts are the 
only modality of therapy for which there is histologic 
evidence, in humans, of regeneration of new attachment 
composed of new bone, cementum and periodontal liga-
ment coronal to the base of the previous osseous defect. 
This has not been observed with other forms of regene-
rative periodontal therapy, which attempt to eliminate 
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bony defects without a bone replacement graft material 
(1).
The bioactive glasses have been used extensively in 
medicine for middle ear surgery and have been applied 
to dentistry in the treatment of bone defects, ridge pres-
ervation and periodontal bone defects. Bioactive ceram-
ics have been used clinically to repair bone defects ow-
ing to their biological affinity to living bone; i.e. the ca-
pability of direct bonding to living bone, their so-called 
bioactivity. (2)
During periodontal therapy, deep intraosseous defects 
represent a major challenge for the clinician, often re-
quiring access by flap surgery alone or in association 
with bone-regenerative procedures. This study was de-
signed to evaluate the additional efficacy of a bioactive 
alloplast, namely PerioGlas, in comparison with open 
flap debridement only.
Materials and Methods
Subject selection criteria
8 volunteers aged between 20-65 years, with at least 
two collateral osseous defects were selected from those 
reporting to the out patients’ department of A.B. Shetty 
Memorial Institute of Dental Sciences, Deralakatte, 
Mangalore.
Inclusion criteria
1 Two or more sites showing periodontal osseous de-
fects in different quadrants with pocket probing depth 
≥ 6mm. 
2 No medical problems that contraindicated routine 
periodontal surgery.
3 Patients who had not taken antibiotics within 6 months 
of initial examination. 
4 No periodontal surgery in the areas to be treated with-
in the last 12 months.
5 No known allergy to materials and drugs used or pre-
scribed in this study, including silica products.
Exclusion criteria
1 Subject has a medical condition or therapeutic regi-
men that would decrease the probability of soft tissue 
and bone healing.
2 Pregnant patients.
3 Smokers.
4 Patients with previously implanted materials, natural 
or synthetic and physical barriers in the selected de-
fects.
5 Patients who did not show any improvement in oral 
hygiene after phase I therapy.
6 Patients who did not accept the terms and conditions 
of the study.
Data Collection
All participants, following an initial examination and 
treatment planning appointment, were given detailed 
instructions in plaque control measures and were then 
subjected to full mouth scaling and root planing. A split 
mouth model was employed in this study. 2 of the bilat-
eral defects were randomly chosen as Site A - test (open 
flap debridement with PerioGlas) or Site B - control 
(open flap debridement only).
Postoperatively, subjects were prescribed antibiotic 
100mg Doxycycline, and analgesic Brufen 400mg. Pa-
tients were instructed to rinse with 10 ml of 0.2% chlo-
rhexidine gluconate twice daily.
The following parameters were recorded at baseline, 3 
months, 6 months and 9 months.
1 Plaque index – Silness & Loe, 1964 (3).
2 Gingival index – Loe & Silness, 1963 (4).
3 Probing pocket depth - measured from the crest of 
the gingival margin to the base of the pocket.
4 Clinical attachment level – Measured from cemen-
toenamel junction to the base of pocket.
5 Recession – Measured from the fixed reference point 
to the  gingival margin.
6 Standardised radiographs of the experimental and 
control sites were taken using a paralleling technique 
with a film holder. This was taken to measure the bone 
fill and the alveolar crest resorption.
Soft Tissue Parameters
Using the apical margin of the customized acrylic stent 
as the fixed reference point (FRP) the following meas-
urements were made at the proximal line angle of the 
tooth with the associated bony defect.  Only one site 
representing the same deepest point of the defect was 
included. 
The following measurements were recorded for test and 
control teeth by a single investigator using a Williams 
graduated periodontal probe.
1 Stent (FRP)  to Cementoenamel junction (CEJ)
2 Stent (FRP)  to gingival margin (GM)
3 Stent (FRP) to base of the pocket (BOP)
The following calculations were made from the clinical 
measurements recorded:
1 Pocket Depth = (FRP to BOP) - (FRP to GM)
2 Clinical attachment level = (FRP to BOP) - (FRP to 
CEJ)
3 Increase in gingival recession = (FRP to GM at recall 
interval) - (FRP to GM at baseline).
These measurements were made at baseline, 3 months, 
6 months and 9 months.
Radiographic / hard tissue parameters :
Standardized intra oral periapical radiographs of each 
defect site using parrelling cone technique with film 
holders (XCP kit) and a millimeter grid (X-ray mesh) 
were taken, preoperatively and post-operatively at 3 
months, 6 months and 9 months.  Radiographic evalua-
tion was performed on an X-ray viewer (Fig. 1 and 2). 
Bone defect depth was measured preoperatively and 
post-operatively at 3 months, 6 months and 9 months 
as the distance from the alveolar crest to the base of the 
bone defect. 
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The Base of defect (BOD) was defined as the most coro-
nal point where the periodontal ligament space showed 
continuous width. (5) 
The alveolar crest (AC) level was taken as the crossing 
of the alveolar crest with the root surface. (5)
If several bony contours could be identified, the most 
apical that crossed the root was defined as BOD and the 
most coronal as the AC. (6)
The following calculations were made from the radio-
graphs:
Amount of defect fill = Initial defect depth – defect 
depth at recalled time interval.
Percentage  (%) of defect fill = Amount of defect fill / 
baseline defect depth x 100. These measurements were 
made at baseline, 3 months, 6 months and 9 months.
Statistical analysis
The obtained data were then subjected to statistical 
analysis. The Mann-Whitney U test was used to com-
pare the results between site A (test) and site B (control) 
groups. The Wilcoxon sign rank sum test was used to 
compare the results between the various time intervals.
Results
The plaque index, gingival index, probing depth showed 
no statistical difference between any of the test and con-
trol sites at any point of time. Similarly, clinical attach-
ment level and gingival recession (Table 1) showed no 
statistical difference between any of the test and control 
sites at any point of time. However, the bone fill (Table 
2 and Fig. 3 ) and crestal bone resorption showed dif-
ferences.
Fig. 1. Site A: Baseline, Site B: Baseline. 
Fig. 2. Site A: 9 months, Site B: 9 months. 
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Fig. 3. Comparison of mean percentage bone fill between Site A and 
Site B.
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ns- not significant. 
sig- significant.
Table 2. Inter-group comparison of percentage bone fill between test site 
(site A) and control site (site B) at 3 months, 6 months and 9 months.
SITE N MEAN 
STD. 
DEVIATION 
Z test
PD Baseline 
A
B
8
8
8.5000 
8.2500 
1.4142 
1.5811 
0.1070 
p=0.914 ns 
PD 3 months 
A
B
8
8
5.6250 
6.3750 
1.3025 
1.8468 
0.7550 
p=0.45 ns 
PD 6 months 
A
B
8
8
4.5000 
5.6250 
0.9258 
1.5980 
1.3610 
p=0.174 ns 
PD 9 months 
A
B
8
8
4.2500 
5.1250 
1.0351 
1.3562 
1.3510 
p=0.177 ns 
CAL Baseline 
A
B
8
8
7.6250 
7.3750 
2.6693 
2.3867 
0.05400 
p=0.957 ns 
CAL 3 months 
A
B
8
8
6.2500 
7.2500 
2.7124 
2.6592 
0.6380 
p=0.524 ns 
CAL 6 months 
A
B
8
8
4.8750 
7.0000 
2.9001 
1.7255 
1.2720 
p=0.204 ns 
CAL 9 months 
A
B
8
8
4.5000 
6.5000 
3.2950 
2.6186 
1.1700 
p=0.242 ns 
Increase in gingival 
recession at 3 months 
A
B
8
8
0.3750 
0.7500 
 0.51755 
 0.70711 
1.1200 
p=0.263 ns 
Increase in gingival 
recession at 6 months 
A
B
8
8
0.5000 
1.0000 
 0.53452 
 0.53452 
1.72 
p=0.085 ns 
Increase in gingival 
recession at 9 months 
A
B
8
8
0.5000 
0.8750 
 0.53452 
 0.64087 
1.20 
p=0.328 ns 
Table 1. Comparison of  (PD), (CAL) and increase in gingival recession between test (Site A) 
and control (Site B) site at baseline, 3,6, and 9 months.
Time interval Site N Mean 
Std. 
Deviation
Z test 
At 3 months 
A
B
8
8
31.763 
13.600 
20.885 
15.256 
1.96200 
p=0.05 sig 
At 6 months 
A
B
8
8
46.338 
28.588 
15.725 
15.725 
1.98500 
p=0.049 sig 
At 9 months 
A
B
8
8
55.188 
36.225 
15.900 
15.796 
2.01200 
p=0.046 sig 
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Discussion
Loss of alveolar bone is one of the characteristic signs 
of destructive periodontal disease and is generally 
considered to represent the anatomical sequela to the 
apical spread of periodontitis. (7) To be considered as 
a regenerative modality, a material or technique must 
histologically demonstrate that bone, cementum and 
a functional periodontal ligament can be formed on a 
previously diseased root surface. Bone grafts and their 
synthetic substitutes have been used in an attempt to 
gain this therapeutic endpoint. (8)
This study compared the soft tissue and hard tissue 
changes with the use of flap debridement along with al-
loplastic bone graft material, PerioGlas, versus that of 
open flap debridement alone in periodontal intrabony 
osseous defects. 8 systemically healthy patients were 
chosen with bilateral defects for this 9 month study. 
Case selection is particularly important to the use and 
success of bone replacement grafts.  The patient must 
be highly motivated and demonstrate the ability to ef-
fectively remove bacterial plaque from every surface of 
every tooth on a daily basis. Likewise, the patient’s age, 
health and emotional status, social habits such as smok-
ing and tolerance for lengthy dental appointments are 
important considerations. Some studies used test sites 
in one subject while the control in the other. (9) In order 
to nullify the subject differences, bilateral defects in the 
same patient were chosen and randomly divided into 
test and control. 
The plaque and gingival indices showed non-significant 
differences between the test and control groups. The re-
sults could be due to the lack of improvement in home 
care. This is similar to the findings of Zamet et al. (10) 
who observed no significant change in plaque index 
or gingival index 12-months postsurgery compared to 
baseline. An overall improvement in the probing depth 
and attachment level was noted in both test and control 
groups. The probing depth in test and control group at 
any time interval showed no statistical difference. A 
study of longer duration (12 months)  was conducted by 
Froum et al. (11). They compared the repair response of 
bioactive glass synthetic bone graft particles and open 
flap debridement. Comparable values to the present 
study were observed at 9 months. 
The increase in gingival recession showed no statistical 
difference between test and control sites at any time in-
terval. The increase in gingival recession between vari-
ous time intervals was significant in test group. Park et 
al. (9) and Lovelace et al. (12) showed lesser recession 
values, probably due to the fact that these studies were 
of shorter duration (6 months).
While measuring all the soft tissue parameters a fixed 
reference point at the apical edge of the custom made 
acrylic stent was used. Clark et al. (13) have reported 
that the measurements using a stent appear to be bet-
ter than the measurements made using cemento-enamel 
junction as the reference point. However, Trevor Watts 
(14) examined the possible sources of error with regard 
to probing measurement reliability with and without 
stent. He found that the stent made little difference to 
overall reproducibly of probing depths, though it ap-
pears to reduce variation in different areas. 
Healing of the bone defect was a combination of bone 
fill and alveolar crest resorption. The percentage of bone 
fill was significant at 3, 6 and 9 months. At the test site 
the values obtained at various intervals are statistically 
significant. The results of the present study are in gen-
eral agreement with the findings of Zamet et al. (10) in 
their clinical comparison of intrabony defects treated 
with bioactive glass or open flap debridement. The CA-
DIA analysis indicated greater radiographic density and 
volume in bioactive glass treated sites. The conclusion 
that bioactive glass treated sites showed a greater trend to 
improvement compared to open flap debridement treated 
sites is consistent with the findings of the present study.
The crestal resorption was minimal at the end of 9 
months which is much lesser than that observed in the 
study by Froum et al. (11). This could be due to the fact 
that Froum et al conducted a longer follow up study (12 
months). Also, there was a clinical re-entry which was 
done at the end of their study, which could have resulted 
in better observation of the site.
A change of the alveolar bone level was detected radio-
graphically using consecutive radiographs. Projection 
geometry of serial radiographs should be standardized 
to minimize measurement errors. A source of error is 
caused by different angulations between the central 
beam related to the film holder and the film while rela-
tion between teeth and film is fixed. (15) Another source 
of projection artifacts is angulation differences between 
the central beam and the anatomic structures to be im-
aged. (16) Prefabricated film holders like what was used 
in this study may provide projection standardization to 
a certain degree.
The selection of the appropriate imaging technique can-
not overcome the fundamental limitations of intraoral 
radiography, even when the images are of high quality. 
Several studies have demonstrated that intraoral radio-
graphs tend to underestimate the amount of bone loss, 
whereas, radiographic assessment of severe osseous 
destruction was shown to overestimate actual bone 
loss. The use of radio-opaque or transparent millimeter 
grids, does not improve the measurement accuracy. (17) 
Grids like the one used in this study may facilitate the 
measurement process, but they do not account for mag-
nification or distortion.
There were some difficulties encountered in the radio-
graphic analysis because bioactive ceramics have radio-
opacity very similar to bone, which made the height 
measurement somewhat problematic. 
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The treatment success reported in various studies may 
differ which is likely to be in part to the varying mor-
phology of initial defects. In this study, some defects 
were 3-wall defects, while others were 1-wall or a com-
bination of 1-2 walls. It has been reported that 2- and3-
wall defects have the highest potential for regeneration 
when grafting procedures are used. In addition, the 
defects varied according to depth and width, with the 
aforementioned study reporting better predictability 
with deep, narrow defects versus shallow, wide ones. It 
is hard to control these variables in a clinical investiga-
tion, but the potential effects of this variability on the 
results need to be realized. However, even in the best 
of circumstances, it is impossible to find matched os-
seous defects. Randomization may help to control this 
variable.
Within the limits of this study, the following conclu-
sions can be drawn.
• There were no differences in probing depth reduction, 
gain in clinical attachment level and increase in gingi-
val recession between the two groups. 
• The sites treated with bioactive glass showed signifi-
cant improvement in bone fill over the sites treated with 
open flap debridement alone. Both groups showed sig-
nificant improvements at the various time intervals.
• The alveolar crest resorption showed significant dif-
ference between the two groups. The control group 
showed significant difference at the recall intervals but 
the test group did not.
• Bioactive glass was well tolerated by the gingival tis-
sues.
• Further studies with a larger sample size are required 
to clarify the beneficial effects of bioactive glass in 
treating periodontal intrabony defects.
The results of the present study are consistent with Gar-
rett’s assessment that “in controlled clinical trials treat-
ing furcation defects and intraosseous defects, non-ab-
sorbable and absorbable synthetic graft materials have 
consistently demonstrated clinical advantages beyond 
that achieved by debridement alone.” (18)
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